Windtree receives Nasdaq bid price deficiency letter; delisting risk if hearing not granted by June 25

WINDTREE THERAPEUTICS INC /DE/

Nasdaq notified Windtree on June 18, 2025 that closing bid price has been below $1.00 for 30 consecutive days.
Company is ineligible for standard 180-day compliance period due to two reverse stock splits >250:1 over prior two years.
Windtree must request a hearing by June 25, 2025, or face suspension/delisting from Nasdaq.
Company intends to request a hearing; automatic stay of delisting pending hearing and any extension granted by Panel.
Common stock continues trading under symbol WINT; no assurance of regaining compliance.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.